PHI with Amyelocephalus
How does this condition affect your private health insurance?
Amyelencephaly is a rare, severe congenital malformation characterized by the complete absence of the brain and spinal cord, resulting from a profound failure of neural tube development during early embryonic stages. This condition is considered a variant of anencephaly with amyelia. Affected fetuses typically do not survive to term or die shortly after birth due to the catastrophic lack of central nervous system function critical for vital processes. Diagnosis is usually made prenatally via ultrasound. It is a uniformly fatal condition with no known treatment, representing one of the most extreme and devastating forms of neural tube defects, leading invariably to death.
PKV Risk Assessment
Individual, specialized PHI providers may still insure you, but with a significant surcharge.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Present from conception; survival typically hours to days post-birth.
Duration of Illness (Lifetime)
Extremely short; typically hours to days post-birth.
Cost of Treatment (Initial)
Primarily costs associated with prenatal diagnosis, delivery, and palliative care; no curative treatment.
Cost of Treatment (Lifetime)
Minimal, as survival is extremely brief and no long-term treatment exists.
Mortality Rate
Virtually 100%, usually prenatally or within hours/days of birth.
Risk of Secondary Damages
Not applicable; the primary condition is universally fatal, precluding secondary damage in a survival context.
Probability of Full Recovery
0%; the condition is invariably fatal.
Underlying Disease Risk
Low; occasionally associated with chromosomal anomalies, but amyelencephaly itself is the overwhelming primary defect.